Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)

• Autores: Christine Adrion
• Localización: BMJ, ISSN-e 0959-535X, Vol. 352, Nº. 4, 2016
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)